Edition:
United States

OpGen Inc (OPGN.OQ)

OPGN.OQ on NASDAQ Stock Exchange Capital Market

0.19USD
15 Dec 2017
Change (% chg)

$-0.01 (-2.99%)
Prev Close
$0.20
Open
$0.21
Day's High
$0.21
Day's Low
$0.19
Volume
233,799
Avg. Vol
279,516
52-wk High
$1.85
52-wk Low
$0.18

Latest Key Developments (Source: Significant Developments)

Opgen reports 2017 third quarter financial results
Tuesday, 7 Nov 2017 04:05pm EST 

Nov 7 (Reuters) - Opgen Inc ::Opgen reports 2017 third quarter financial results and provides business update.Q3 loss per share $0.07.Q3 revenue $745,000 versus $760,000.  Full Article

OpGen Q2 loss per share $0.15​
Tuesday, 8 Aug 2017 04:01pm EDT 

Aug 8 (Reuters) - OpGen Inc :OpGen reports 2017 second quarter financial results and provides business update.Q2 revenue $700,000 versus $1.2 million.OpGen Inc qtrly ‍net loss per common share, basic and diluted, $0.15​.OpGen - ‍first of rapid tests expected to be tested at third-party clinical evaluation sites in q4 and launched as an ruo test in first half of 2018​.OpGen Inc - ‍cash and cash equivalents were $0.2 million as of June 30, 2017 compared with $4.1 million as of december 31, 2016​.OpGen Inc - ‍expect a decrease in operating expenses of approximately 25% to 30% in second half of 2017​.  Full Article

Opgen Acuitas MDRO gene test approved by NY State Department Of Health
Wednesday, 12 Jul 2017 01:28pm EDT 

July 12 (Reuters) - Opgen Inc :Opgen acuitas® mdro gene test approved by ny state department of health.Opgen inc says new york state department of health has approved acuitas mdro gene test for use by physicians and healthcare providers in state.  Full Article

Opgen files for offering up to 13.7 mln shares of co's common stock
Thursday, 29 Jun 2017 06:18am EDT 

June 29 (Reuters) - Opgen Inc ::Opgen Inc files for offering up to 13.7 million shares of co's common stock and common warrants to purchase aggregate of 6.85 million shares of co's common stock.  Full Article

Opgen Qtrly net loss per common share $0.19
Wednesday, 26 Apr 2017 04:00pm EDT 

April 26 (Reuters) - Opgen Inc ::Opgen announces 2017 first quarter financial results.Q1 revenue $800,000 versus $1.1 million.Qtrly net loss per common share - basic and diluted $0.19.  Full Article

OpGen announces Q4 revenue of $1 mln
Thursday, 23 Mar 2017 04:01pm EDT 

OpGen Inc : OpGen announces 2016 fourth quarter and year end financial results . Q4 revenue fell 24 percent to $1.0 million .OpGen Inc qtrly loss per share $0.21.  Full Article

OpGen sees 24 pct fall in Q4 revenue
Thursday, 26 Jan 2017 05:27pm EST 

OpGen Inc - : Total revenue for Q4 of 2016 is expected to be approximately $1.0 million, a decrease of approximately 24% .Net loss for Q4 of 2016 is expected to be in range of approximately $4.6 million and $5.1 million.  Full Article

OpGen collaborates with Merck to develop rapid diagnostics and informatics tools to help combat antimicrobial resistance
Monday, 14 Nov 2016 07:00am EST 

Merck & Co Inc :OpGen Inc - entered into research collaboration with Merck to develop rapid diagnostics, it products to help combat threat of antimicrobial resistance.  Full Article

Opgen - Kevin Krenitsky resigns as president of company
Friday, 2 Sep 2016 06:41pm EDT 

Opgen Inc : On August 31, 2016, Kevin Krenitsky, M.D. resigned as president of company effective immediately - SEC filing Source: (http://bit.ly/2c1d3y8) Further company coverage: [OPGN.O] ((bangalore.newsroom@thomsonreuters.com;)).  Full Article

OpGen files for stock shelf of up to $50 million
Friday, 26 Aug 2016 05:41pm EDT 

OpGen Inc : Files for stock shelf of up to $50 million - SEC filing .In addition, selling shareholders offering up to 185,250 shares of co's common stock underlying warrant.  Full Article

BRIEF-Opgen reports 2017 third quarter financial results

* Opgen reports 2017 third quarter financial results and provides business update